Tokyo, May 3 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061443) titled 'COMPARISON OF THE DIRECT EFFECTS OF DRY NEEDLING AND ELECTRICAL DRY NEEDLING ON TRIGGER POINT AREA, FASCIA THICKNESS, PAIN, AND RANGE OF MOTION IN LUMBAR MYOFASCIAL PAIN SYNDROME' on May 2.

Study Type: Interventional

Study Design: Basic Design - Parallel Randomization - Randomized Blinding - Double blind -all involved are blinded Control - Active

Primary Sponsor: Institute - Hasanuddin University

Condition: Condition - Myofascial Pain Syndrome Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - To analyze the comparative effects of dry needling and electrical dry needling on the area of MTrPs, fascia thickness, pain, and range of joint motion in lumbar myofascial pain syndrome. Basic objectives2 - Efficacy

Intervention: Interventions/Control_1 - A minimally invasive therapy technique that involves inserting thin, filiform needles into trigger points in muscles affected by myofascial pain syndrome in the lumbar region. The needles penetrate the skin and contact the trigger point, then manipulate the needle until a local twitch response occurs. Procedure: F: 1 treatment I: 40-75 mm T: Pistoning, local twitch response (LTR) T: 3 minutes Interventions/Control_2 - A minimally invasive therapy technique similar to conventional dry needling but using a combination of Transcutaneous Electrical Neurostimulation. Procedure: F: 1x therapy I: 2 Hz T: Needles inserted into trigger points in situ + TENS stimulation T: 10 minutes

Eligibility: Age-lower limit - 20 years-old = Gender - Male and Female Key inclusion criteria - Inclusion criteria were individuals aged 20 to 60 years, patients with subacute or chronic lumbar myofascial pain syndrome, confirmed presence of myofascial trigger points and fascial thickening in the lumbar region as verified by ultrasonography, and limitation in lumbar range of motion. Key exclusion criteria - Exclusion criteria include: (1) contraindications to needling, (2) open wounds or infection at the intervention site, (3) presence of pacemakers or implantable defibrillators, (4) pregnancy or breastfeeding, (5) history of peripheral neuropathy or progressive neurological disorders, and (6) current use of systemic anticoagulants, NSAIDs, or routine analgesics. Target Size - 52

Recruitment Status: Recruitment status - Preinitiation Date of protocol fixation - 2026 Year 04 Month 04 Day Date of IRB - 2026 Year 04 Month 07 Day Anticipated trial start date - 2026 Year 05 Month 03 Day Last follow-up date - 2026 Year 05 Month 17 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070300

Disclaimer: Curated by HT Syndication.